Clinical Trials Directory

Trials / Completed

CompletedNCT03215446

Evaluate the Muscle Protection Effect of Sevoflurane Sedation in Vascular Surgery

Evaluation of Total (Pre and Post) Conditioning on Rhabdomyolysis of Sedation With Sevoflurane Versus Propofol in Vascular Surgery With Clamping

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
164 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Halogenated anaesthetic agents (HAA) may induce protective processes by pre-conditioning the myocardium. All of the literature shows that HAA induce pre-conditioning, thanks to a class effect, and Sevoflurane is the most widely used today. In humans, the protective effects of halogenated agents have principally been studied in heart surgery and have shown encouraging clinical results. It seems that HAA induce both pre-conditioning of the myocardium (early and late) and post conditioning. Given these protective effects of HAA, in 2007, the American Heart Association (AHA) recommended the use of HAA for anaesthesia maintenance in non-cardiac surgery in patients with a high cardio-vascular risk. The aim of this study is to show a decrease in rhabdomyolysis and tissue distress (kidneys, myocardium and liver), thanks to Sevoflurane anaesthesia, in the post-operative period following vascular surgery with clamping

Conditions

Interventions

TypeNameDescription
DRUGmaintenance of anaesthesia with propofol
DRUGmaintenance of anaesthesia with sevoflurane

Timeline

Start date
2016-06-13
Primary completion
2018-05-29
Completion
2018-10-19
First posted
2017-07-12
Last updated
2021-01-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03215446. Inclusion in this directory is not an endorsement.